Skip to main
JNJ

JNJ Stock Forecast & Price Target

JNJ Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 32%
Buy 32%
Hold 37%
Sell 0%
Strong Sell 0%

Bulls say

Johnson & Johnson is a leader in the healthcare industry, with a strong focus on innovation and sustainability. Their two divisions are positioned for growth through catalysts and acquisitions, and their experienced CEO brings a strategic vision for the future. With a long history and diverse portfolio, Johnson & Johnson is well-positioned for continued success in the global market.

Bears say

Johnson & Johnson is facing significant challenges in the near future, including increased competition and legal troubles. Their restructuring efforts and focus on high-growth areas may not be enough to offset the potential impact of these challenges. Additionally, the company's reliance on the US market for over half of its revenue may limit its growth potential. While they maintain a strong financial position, ongoing litigation and potential settlements could negatively impact their cash reserves.

JNJ has been analyzed by 19 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 32% recommend Buy, 37% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Johnson & Johnson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Johnson & Johnson (JNJ) Forecast

Analysts have given JNJ a Buy based on their latest research and market trends.

According to 19 analysts, JNJ has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $267.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $267.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Johnson & Johnson (JNJ)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.